Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07477860 · ClinicalTrials.gov registry record · Phase 1
Achilles Tendinopathy Embolization
A Phase 1 study, sponsored by Joint & Vascular Institute.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT07477860 is a Phase 1 study that is actively recruiting participants, run by Joint & Vascular Institute. The registered enrollment target is 10 participants.
The verdict
NCT07477860, a Phase 1 study, is actively recruiting participants, sponsored by Joint & Vascular Institute.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn determine the feasibility of arterial embolization using Lipiodol emulsion to safely and effectively treat chronic Achilles tendon pain due to Achilles tendinopathy in adults aged 25 to 80. The main questions it aims to answer are: 1. Does this procedure successfully reduce chronic Achilles tendon pain as measured by the Visual Analog Scale (VAS) over 12 months? 2. How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device? Participants will: * Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels supplying the Achilles tendon. * Receive a phone call one day after the procedure to check for early side effects. * Participate in four follow-up visits over the course of one year (at 1, 3, 6, and 12 months). Complete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.
Interventions
- DEVICE LipioJoint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2028-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07477860
The ClinicalTrials.gov registry entry for NCT07477860 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joint & Vascular Institute, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LipioJoint is the first listed.
NCT07477860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07477860 about?
NCT07477860 is a clinical study titled "Achilles Tendinopathy Embolization". The goal of this clinical trial is to learn determine the feasibility of arterial embolization using Lipiodol emulsion to safely and effectively treat chronic Achilles tendon pain due to Achilles tendinopathy in adults aged 25 to 80. The main questions it aims to answer are: 1. Does this procedure ...
What is the current status of trial NCT07477860?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2026-04-01. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07477860?
The interventions under investigation include: LipioJoint (DEVICE).
Who is sponsoring clinical trial NCT07477860?
This trial is sponsored by Joint & Vascular Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.